LivaNova PLC revenue breakdown overview

LivaNova PLC revenue for the last year amounted to 1.25 B USD, the most of which — 683.51 M USD — came from its highest performing source at the moment, Cardiopulmonary, the year earlier bringing 588.98 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought LivaNova PLC 695.08 M USD, and the year before that — 635.04 M USD.